CRC
EDIT icon

Curi RMB Capital’s Editas Medicine EDIT Stock Holding History

Curi RMB Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,536
Closed -$218K – 490
2022
Q4 		$218K Hold
24,536
– – 0.01% 449
2022
Q3 		$300K Hold
24,536
– – 0.01% 406
2022
Q2 		$290K Sell
24,536
-59,479
-71% -$797K 0.01% 413
2022
Q1 		$1.6M Buy
84,015
+22,688
+37% +$422K 0.05% 213
2021
Q4 		$1.63M Buy
61,327
+12,739
+26% +$438K 0.05% 220
2021
Q3 		$2M Buy
48,588
+8
+0% +$438 0.07% 207
2021
Q2 		$2.75M Buy
48,580
+26,014
+115% +$961K 0.09% 178
2021
Q1 		$948K Buy
+22,566
New +$1.29M 0.04% 267

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Curi RMB Capital's EDIT Position: Q1 2023 in Review

Curi RMB Capital sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 24,536 shares — an estimated $218K sold.

Curi RMB Capital first reported a position in EDIT in Q1 2021 and held it in 8 quarters. The position peaked at $2.75M in Q2 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Curi RMB Capital reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Curi RMB Capital sold 24,536 Editas Medicine shares in Q1 2023, an estimated $218K.
  • Curi RMB Capital first reported a position in Editas Medicine in Q1 2021 and held it in 8 quarters.
  • Curi RMB Capital's Editas Medicine position peaked at $2.75M in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Curi RMB Capital's 13F filing for Q1 2023, filed 11 May 2023.